Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius Sells 216 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president now directly owns 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Mark Brosius also recently made the following trade(s):

• On Wednesday, June 4th, Mark Brosius sold 215 shares of Intuitive Surgical stock. The stock was sold at an average price of $552.07, for a total value of $118,695.05.
• On Monday, June 2nd, Mark Brosius sold 215 shares of Intuitive Surgical stock. The stock was sold at an average price of $549.06, for a total value of $118,047.90.
• On Friday, May 16th, Mark Brosius sold 20 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.81, for a total value of $11,276.20.
• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.00, for a total value of $12,386.00.
• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $551.97, for a total value of $12,143.34.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $557.08 on Friday. The stock’s fifty day moving average is $521.99 and its 200 day moving average is $539.26. Intuitive Surgical, Inc. has a fifty-two week low of $413.52 and a fifty-two week high of $616.00. The firm has a market capitalization of $199.67 billion, a PE ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the firm posted $1.50 EPS. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of ISRG. Atala Financial Inc purchased a new stake in Intuitive Surgical during the 4th quarter valued at $25,000. Chilton Capital Management LLC increased its stake in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the period. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth $26,000. Global Financial Private Client LLC increased its stake in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 38 shares during the period. Finally, Elite Financial Inc. purchased a new stake in Intuitive Surgical in the first quarter worth $26,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ISRG shares. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Evercore ISI dropped their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. Royal Bank of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Piper Sandler decreased their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.